Drug intelligence / Profile preview

Vytomo Gold

Development stage: Unknown
Lead developer: Rantomo Lifesciences
Modality: Small Molecules
Administration: Oral

Overview

Vytomo Gold is a nutraceutical dietary supplement developed and marketed by Rantomo Lifesciences Bharat Private Limited, a pharmaceutical company based in Mumbai, India. Formulated as a softgel capsule for oral administration, it contains a combination of omega-3 fatty acids, essential vitamins, and minerals. The product is designed to support general health by boosting immunity, enhancing brain function, and providing antioxidant protection against oxidative stress. It is currently commercially available in the Indian market and is distributed through various pharmacy platforms.

Brand names: Vytomo Gold

Beyond the preview

Go deeper on Vytomo Gold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vytomo Gold.

Explore the full profile